![]()
|
|
||||||||
J. Biol. Chem., Vol. 281, Issue 25, 17259-17265, June 23, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

1



¶2
From the
Department of Cancer Immunology and AIDS, Dana Farber Cancer Institute, Boston, Massachusetts 02115, and Departments of
Pathology and ¶Neurology, Harvard Medical School, Boston, Massachusetts 02115
Human immunodeficiency virus-1 (HIV-1) Vif overcomes the anti-viral activity of APOBEC3G by targeting it for ubiquitination via a Cullin 5-ElonginB-ElonginC (Cul5-EloBC) E3 ligase. Vif associates with Cul5-EloBC through a BC-box motif that binds EloC, but the mechanism by which Vif selectively recruits Cul5 is poorly understood. Here we report that a region of Vif (residues 100-142) upstream of the BC-box binds selectively to Cul5 in the absence of EloC. This region contains a zinc coordination site HX5CX17-18CX3-5H (HCCH), with His/Cys residues at positions 108, 114, 133, and 139 coordinating one zinc ion. The HCCH zinc coordination site, which is conserved among primate lentivirus Vif proteins, does not correspond to any known class of zinc-binding motif. Mutations of His/Cys residues in the HCCH motif impair zinc coordination, Cul5 binding, and APOBEC3G degradation. Mutations of conserved hydrophobic residues (Ile-120, Ala-123, and Leu-124) located between the two Cys residues in the HCCH motif disrupt binding of the zinc-coordinating region to Cul5 and inhibit APOBEC3G degradation. The Vif binding site maps to the first cullin repeat in the N terminus of Cul5. These data suggest that the zinc-binding region in Vif is a novel cullin interaction domain that mediates selective binding to Cul5. We propose that the HCCH zinc-binding motif facilitates Vif-Cul5 binding by playing a structural role in positioning hydrophobic residues for direct contact with Cul5.
Received for publication, March 15, 2006 , and in revised form, April 24, 2006.
* This work was supported by National Institutes of Health Grants AI36186 and AI62555. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org) contains supplemental data.
1 Supported in part by a National Science Foundation predoctoral fellowship.
2 To whom correspondence should be addressed: Dana-Farber Cancer Inst., JF816, 44 Binney St., Boston, MA 02115. Tel.: 617-632-2154; Fax: 617-632-3113; E-mail: dana_gabuzda{at}dfci.harvard.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. L. DeHart, A. Bosque, R. S. Harris, and V. Planelles Human Immunodeficiency Virus Type 1 Vif Induces Cell Cycle Delay via Recruitment of the Same E3 Ubiquitin Ligase Complex That Targets APOBEC3 Proteins for Degradation J. Virol., September 15, 2008; 82(18): 9265 - 9272. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Stanley, E. S. Ehrlich, L. Short, Y. Yu, Z. Xiao, X.-F. Yu, and Y. Xiong Structural Insight into the Human Immunodeficiency Virus Vif SOCS Box and Its Role in Human E3 Ubiquitin Ligase Assembly J. Virol., September 1, 2008; 82(17): 8656 - 8663. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gallois-Montbrun, R. K. Holmes, C. M. Swanson, M. Fernandez-Ocana, H. L. Byers, M. A. Ward, and M. H. Malim Comparison of Cellular Ribonucleoprotein Complexes Associated with the APOBEC3F and APOBEC3G Antiviral Proteins J. Virol., June 1, 2008; 82(11): 5636 - 5642. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Dang, L. M. Siew, and Y.-H. Zheng APOBEC3G Is Degraded by the Proteasomal Pathway in a Vif-dependent Manner without Being Polyubiquitylated J. Biol. Chem., May 9, 2008; 283(19): 13124 - 13131. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. F. Mulder, A. Harari, and V. Simon Cytidine deamination induced HIV-1 drug resistance PNAS, April 8, 2008; 105(14): 5501 - 5506. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Mahrour, W. B. Redwine, L. Florens, S. K. Swanson, S. Martin-Brown, W. D. Bradford, K. Staehling-Hampton, M. P. Washburn, R. C. Conaway, and J. W. Conaway Characterization of Cullin-box Sequences That Direct Recruitment of Cul2-Rbx1 and Cul5-Rbx2 Modules to Elongin BC-based Ubiquitin Ligases J. Biol. Chem., March 21, 2008; 283(12): 8005 - 8013. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Wang, C. Tian, W. Zhang, K. Luo, P. T. N. Sarkis, L. Yu, B. Liu, Y. Yu, and X.-F. Yu 7SL RNA Mediates Virion Packaging of the Antiviral Cytidine Deaminase APOBEC3G J. Virol., December 1, 2007; 81(23): 13112 - 13124. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mehle, H. Wilson, C. Zhang, A. J. Brazier, M. McPike, E. Pery, and D. Gabuzda Identification of an APOBEC3G Binding Site in Human Immunodeficiency Virus Type 1 Vif and Inhibitors of Vif-APOBEC3G Binding J. Virol., December 1, 2007; 81(23): 13235 - 13241. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Luo, E. Ehrlich, Z. Xiao, W. Zhang, G. Ketner, and X.-F. Yu Adenovirus E4orf6 assembles with Cullin5-ElonginB-ElonginC E3 ubiquitin ligase through an HIV/SIV Vif-like BC-box to regulate p53 FASEB J, June 1, 2007; 21(8): 1742 - 1750. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Huthoff and M. H. Malim Identification of Amino Acid Residues in APOBEC3G Required for Regulation by Human Immunodeficiency Virus Type 1 Vif and Virion Encapsidation J. Virol., April 15, 2007; 81(8): 3807 - 3815. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, P. T. Dolan, Y. Dang, and Y.-H. Zheng Biochemical Differentiation of APOBEC3F and APOBEC3G Proteins Associated with HIV-1 Life Cycle J. Biol. Chem., January 19, 2007; 282(3): 1585 - 1594. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Paul, J. Cui, and E. L. Maynard Zinc binding to the HCCH motif of HIV-1 virion infectivity factor induces a conformational change that mediates protein-protein interactions PNAS, December 5, 2006; 103(49): 18475 - 18480. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |